Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (395)
CYTOKINETICS INC (CYTK)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$71.48
Total Value
$357.40K
Shares Held After
10,784
% of Holdings
31.7%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
10,000
Price
$12.11
Total Value
$121.10K
Shares Held After
124,411
% of Holdings
7.4%
Perspective Therapeutics, Inc. (CATX)
Lantheus Alpha Therapy, LLC — 10% Owner
Shares
78,145
Price
$3.14
Total Value
$245.61K
Shares Held After
11,599,194
% of Holdings
0.7%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
10,000
Price
$3.96
Total Value
$39.60K
Shares Held After
10,000
% of Holdings
100.0%
PULSE BIOSCIENCES, INC. (PLSE)
Teplitsky Liane Rae — Chief Operating Officer
Shares
1,024
Price
$48.80
Total Value
$49.97K
Shares Held After
3,094
% of Holdings
33.1%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
9,683
Price
$2.75
Total Value
$26.66K
Shares Held After
258,688
% of Holdings
3.6%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
34,463
Price
$2.67
Total Value
$91.90K
Shares Held After
1,226,427
% of Holdings
2.7%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
10,257
Price
$2.74
Total Value
$28.11K
Shares Held After
318,480
% of Holdings
3.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
403,571
Price
$1.79
Total Value
$722.59K
Shares Held After
5,257,389
% of Holdings
7.7%
Perspective Therapeutics, Inc. (CATX)
Lantheus Holdings, Inc. — 10% Owner
Shares
78,145
Price
$3.14
Total Value
$245.61K
Shares Held After
11,599,194
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
625
Price
$206.15
Total Value
$128.85K
Shares Held After
17,090
% of Holdings
3.5%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
2,128
Price
$205.19
Total Value
$436.64K
Shares Held After
17,715
% of Holdings
10.7%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
7,271
Price
$204.35
Total Value
$1.49M
Shares Held After
19,843
% of Holdings
26.8%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
26,160
Price
$203.55
Total Value
$5.32M
Shares Held After
27,114
% of Holdings
49.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
12,919
Price
$202.48
Total Value
$2.62M
Shares Held After
53,274
% of Holdings
19.5%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
6,597
Price
$201.47
Total Value
$1.33M
Shares Held After
66,193
% of Holdings
9.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
300
Price
$200.56
Total Value
$60.17K
Shares Held After
72,790
% of Holdings
0.4%
Jushi Holdings Inc. (JUSH)
Cacioppo James — Director
Shares
71,686
Price
$0.51
Total Value
$36.56K
Shares Held After
4,475,148
% of Holdings
1.6%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
1,099
Price
$10.24
Total Value
$11.25K
Shares Held After
366,529
% of Holdings
0.3%
LivaNova PLC (LIVN)
Bianchi Francesco — Director
Shares
1,650
Price
$79.72
Total Value
$131.54K
Shares Held After
7,934
% of Holdings
17.2%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
100,000
Price
$0.05
Total Value
$5.00K
Shares Held After
690,167
% of Holdings
14.5%
Quoin Pharmaceuticals, Ltd. (QNRX)
Carter Denise P. — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,709
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Myers Michael — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,713
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Lawlor Sally Bridget — Chief Financial Officer
Shares
10,244
Price
$4.88
Total Value
$49.99K
Shares Held After
10,684
% of Holdings
95.9%
Quoin Pharmaceuticals, Ltd. (QNRX)
Culverwell Anthony James — Director
Shares
6,146
Price
$4.88
Total Value
$29.99K
Shares Held After
40,364
% of Holdings
15.2%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP&CFO
Shares
2,850
Price
$72.80
Total Value
$207.48K
Shares Held After
171,843
% of Holdings
1.6%
NovaBridge Biosciences (NBP)
Xu Cong Claire — EVP, Clinical Development
Shares
3,282
Price
$0.79
Total Value
$2.59K
Shares Held After
304,201
% of Holdings
1.1%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
1,276
Price
$4.66
Total Value
$5.95K
Shares Held After
454
% of Holdings
73.8%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,525
Price
$1.56
Total Value
$3.95K
Shares Held After
2,896
% of Holdings
46.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
28,188
Price
$106.20
Total Value
$2.99M
Shares Held After
114,024
% of Holdings
19.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
11,514
Price
$105.37
Total Value
$1.21M
Shares Held After
142,212
% of Holdings
7.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
23,072
Price
$104.59
Total Value
$2.41M
Shares Held After
153,726
% of Holdings
13.0%
THERMO FISHER SCIENTIFIC INC. (TMO)
Pettiti Gianluca — President&COO
Shares
3,733
Price
$614.38
Total Value
$2.29M
Shares Held After
23,216
% of Holdings
13.9%
THERMO FISHER SCIENTIFIC INC. (TMO)
Pettiti Gianluca — President&COO
Shares
400
Price
$614.38
Total Value
$245.75K
Shares Held After
23,216
% of Holdings
1.7%
Encompass Health Corp (EHC)
Darby John Patrick — EVP, Gen Counsel&Secretary
Shares
4,858
Price
$121.09
Total Value
$588.26K
Shares Held After
75,041
% of Holdings
6.1%
Encompass Health Corp (EHC)
Price Andrew L — Chief Accounting Officer
Shares
5,211
Price
$120.93
Total Value
$630.17K
Shares Held After
69,483
% of Holdings
7.0%
FENNEC PHARMACEUTICALS INC. (FENC)
Sayad Pierre Sargis — Chief Medical Officer
Shares
12,000
Price
$12.18
Total Value
$146.16K
Shares Held After
9,519
% of Holdings
55.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
217
Price
$69.10
Total Value
$14.99K
Shares Held After
525,217
% of Holdings
0.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.23
Total Value
$341.18K
Shares Held After
525,000
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Edwards Lifesciences Corp (EW)
Dahl Andrew M. — SVP, Corporate Controller
Shares
544
Price
$91.06
Total Value
$49.53K
Shares Held After
14,868
% of Holdings
3.5%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.24
Total Value
$526.80K
Shares Held After
377,820
% of Holdings
1.9%
ICU MEDICAL INC/DE (ICUI)
Bonnell Brian Michael — Chief Financial Officer
Shares
1,113
Price
$173.91
Total Value
$193.57K
Shares Held After
62,443
% of Holdings
1.8%
ICU MEDICAL INC/DE (ICUI)
Bonnell Brian Michael — Chief Financial Officer
Shares
4,568
Price
$173.44
Total Value
$792.29K
Shares Held After
63,556
% of Holdings
6.7%
ICU MEDICAL INC/DE (ICUI)
Bonnell Brian Michael — Chief Financial Officer
Shares
1,914
Price
$172.12
Total Value
$329.44K
Shares Held After
68,124
% of Holdings
2.7%
ICU MEDICAL INC/DE (ICUI)
Bonnell Brian Michael — Chief Financial Officer
Shares
1,712
Price
$171.05
Total Value
$292.84K
Shares Held After
70,038
% of Holdings
2.4%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
10,000
Price
$70.24
Total Value
$702.40K
Shares Held After
58,555
% of Holdings
14.6%
Shares
3,500
Price
$0.05
Total Value
$171.50
Shares Held After
9,384,256
% of Holdings
0.0%
Sensus Healthcare, Inc. (SRTS)
Sachetta Eric — Director
Shares
27,304
Price
$3.54
Total Value
$96.60K
Shares Held After
294,784
% of Holdings
9.3%
Showing 101–150 of 395 transactions (page 3 of 8)